Offer - Urjas Oil for just ₹ 1 X
Triolmesar 20 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Triolmesar 20 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Triolmesar 20 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Triolmesar 20 Tablet include Upper respiratory tract infection. While these are the most often observed Triolmesar 20 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Triolmesar 20 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Triolmesar 20 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. Warnings related to Triolmesar 20 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Triolmesar 20 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. The section on Triolmesar 20 Tablet contraindications lists all such conditions.
Drug interactions for Triolmesar 20 Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Triolmesar 20 Tablet is considered not safe while driving, and is not addictive.
Triolmesar 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmesar 20 Tablet safe for pregnant women?
Pregnant women can take Tri Olmesar without worrying about any side effects.
Is the use of Triolmesar 20 Tablet safe during breastfeeding?
Tri Olmesar is safe for breastfeeding women.
What is the effect of Triolmesar 20 Tablet on the Kidneys?
Tri Olmesar has very mild side effects on the kidneys.
What is the effect of Triolmesar 20 Tablet on the Liver?
Tri Olmesar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Triolmesar 20 Tablet on the Heart?
Tri Olmesar is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Triolmesar 20 Tablet unless your doctor advises you to do so -
Is this Triolmesar 20 Tablet habit forming or addictive?
Forming a habit of Triolmesar 20 Tablet has not been reported.
Interaction between Food and Triolmesar 20 Tablet
Taking Triolmesar 20 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Triolmesar 20 Tablet
Consuming Triolmesar 20 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448